• Published On : Aug-2016 |
  • Pages : 236 Pages |
  • Format :

1. Executive Summary

2. Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Market Introduction
   2.1. Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Market Definition
   2.2. Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Market Taxonomy

3. Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Market Analysis Scenario
   3.1. Market Volume Analysis
3.1.1. Regional Consumption Outlook
   3.2. Pricing Analysis
        3.2.1. Pricing Assumptions
        3.2.2. Price Projections Per Region
   3.3. Market Size (US$ Mn) and Forecast
        3.3.1. Market Size and Y-o-Y Growth
        3.3.2. Absolute $ Opportunity
   3.4. Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Market Overview
        3.4.1. Value Chain
        3.4.3. List of Active Participants
               3.4.3.1. Manufacturers
               3.4.3.2. Distributors
   3.5. Product Overview
   3.6. PEST Analysis By Region
   3.7. Regulatory Scenario
   3.8. ADHD Epidemiology Data By Region
   3.9. Reimbursement

4. Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Market Dynamics
   4.1. Macro-economic Factors
   4.2. Drivers
        4.2.1. Supply Side
        4.2.2. Demand Side
   4.3. Restraints
   4.4. Opportunity
   4.5. Pipeline Analysis

5. Global Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Market Analysis and Forecast, By Drug Type
   5.1. Introduction
        5.1.1. Basis Point Share (BPS) Analysis By Drug Type
        5.1.2. Y-o-Y Growth Projections By Drug Type
   5.2. Market Size (US$ Mn) and Volume(Units) Forecast By Drug Type
        5.2.1. Stimulants
               5.2.1.1. Amphetamine (Adzenys XR ODT, Evekeo)
               5.2.1.2. Methylphenidate (Concerta, Daytrana)
               5.2.1.3. Dextroamphetamine (Dexedrine, ProCentra, Zenzedi)
               5.2.1.4. Dexmethylphenidate
               5.2.1.5. Lisdexamfetamine dimesylate (Vyvanse)
        5.2.2. Non stimulants
               5.2.2.1. Atomoxetine (Strattera)
               5.2.2.2. Bupropion
               5.2.2.3. Guanfacine (Intuniv)
               5.2.2.4. Clonidine (Kapvay)
   5.3. Market Attractiveness Analysis By Drug Type
   5.4. Prominent Trends

6. Global Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Market Analysis and Forecast, By Age Group
   6.1. Introduction
        6.1.1. Basis Point Share (BPS) Analysis By Age Group 
        6.1.2. Y-o-Y Growth Projections By Age Group 
        6.1.3. Comparative Analysis By Age Group 
   6.2. Market Size (US$ Mn) Forecast By Age Group
        6.2.1. Pediatric and neonates
        6.2.2. Adult
   6.3. Market Attractiveness Analysis By Age Group
   6.4. Prominent Trends

7. Global Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Market Analysis and Forecast, By Distribution Channel
   7.1. Introduction
        7.1.1. Basis Point Share (BPS) Analysis By Distribution Channel
        7.1.2. Y-o-Y Growth Projections By Distribution Channel
        7.1.3. Comparative Analysis By Distribution Channel
   7.2. Market Size (US$ Mn) Forecast By Distribution Channel
        7.2.1. Specialty Clinics
        7.2.2. Hospital Pharmacies
        7.2.3. Retail Pharmacies
        7.2.4. E-commerce 
   7.3. Market Attractiveness Analysis By Distribution Channel
   7.4. Prominent Trends

8. Global Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Market Analysis and Forecast, By Region
   8.1. Introduction
        8.1.1. Basis Point Share (BPS) Analysis By Region
        8.1.2. Y-o-Y Growth Projections By Region
   8.2. Market Size (US$ Mn) Forecast By Region
        8.2.1. North America
        8.2.2. Europe
        8.2.3. APAC
        8.2.4. Latin America
        8.2.5. Middle East and Africa (MEA)
   8.3. Market Attractiveness Analysis By Region

9. North America Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Market Analysis and Forecast
   9.1. Introduction
        9.1.1. Basis Point Share (BPS) Analysis By Country
        9.1.2. Y-o-Y Growth Projections By Country
        9.1.3. Key Regulations
   9.2. Market Size (US$ Mn) Forecast By Country
        9.2.1. U.S.
        9.2.2. Canada
   9.3. Market Size (US$ Mn) and Volume(Units) Forecast By Drug Type
        9.3.1. Stimulants
               9.3.1.1. Amphetamine (Adzenys XR ODT, Evekeo)
               9.3.1.2. Methylphenidate (Concerta, Daytrana)
               9.3.1.3. Dextroamphetamine (Dexedrine, ProCentra, Zenzedi)
               9.3.1.4. Dexmethylphenidate
               9.3.1.5. Lisdexamfetamine dimesylate (Vyvanse)
        9.3.2. Non stimulants
               9.3.2.1. Atomoxetine (Strattera)
               9.3.2.2. Bupropion
               9.3.2.3. Guanfacine (Intuniv)
               9.3.2.4. Clonidine (Kapvay)
   9.4. Market Size (US$ Mn) Forecast By Distribution Channel
        9.4.1. Specialty Clinics
        9.4.2. Hospital Pharmacies
        9.4.3. Retail Pharmacies
        9.4.4. E-commerce
   9.5. Market Size (US$ Mn) Forecast By Age Group
        9.5.1. Pediatric and neonates
        9.5.2. Adult
   9.6. Market Attractiveness Analysis
        9.6.1. By Country
        9.6.2. By Drug Type
        9.6.3. By Distribution Channel
        9.6.4. By Age Group 
   9.7. Prominent Trends
   9.8. Drivers and Restraints: Impact Analysis

10.  Latin America Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Market Analysis and Forecast
   10.1. Introduction
        10.1.1. Basis Point Share (BPS) Analysis By Country
        10.1.2. Y-o-Y Growth Projections By Country
        10.1.3. Key Regulations
   10.2. Market Size (US$ Mn) Forecast By Country / Region
        10.2.1. Brazil
        10.2.2. Mexico
        10.2.3. Rest of Latin America
   10.2. Market Size (US$ Mn) and Volume(Units) Forecast By Drug Type
        10.2.1. Stimulants
               10.2.1.1. Amphetamine (Adzenys XR ODT, Evekeo)
               10.2.1.2. Methylphenidate (Concerta, Daytrana)
               10.2.1.3. Dextroamphetamine (Dexedrine, ProCentra, Zenzedi)
               10.2.1.4. Dexmethylphenidate
               10.2.1.5. Lisdexamfetamine dimesylate (Vyvanse)
        10.2.2. Non stimulants
               10.2.2.1. Atomoxetine (Strattera)
               10.2.2.2. Bupropion
               10.2.2.3. Guanfacine (Intuniv)
               10.2.2.4. Clonidine (Kapvay)
   10.3. Market Size (US$ Mn) Forecast By Distribution Channel
        10.3.1. Specialty Clinics
        10.3.2. Hospital Pharmacies
        10.3.3. Retail Pharmacies
        10.3.4. E-commerce
   10.4. Market Size (US$ Mn) Forecast By Age Group
        10.4.1. Pediatric and neonates
        10.4.2. Adult
   10.5. Market Attractiveness Analysis
        10.5.1. By Country
        10.5.2. By Drug Type
        10.5.3. By Distribution Channel
        10.5.4. By Age Group 
   10.6. Prominent Trends
   10.7. Drivers and Restraints: Impact Analysis

11.  Europe Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Market Analysis and Forecast
   11.1. Introduction
        11.1.1. Basis Point Share (BPS) Analysis By Country / Region
        11.1.2. Y-o-Y Growth Projections By Country
        11.1.3. Key Regulations
   11.2. Market Size (US$ Mn) Forecast By Country / Region
        11.2.1. Germany
        11.2.2. France
        11.2.3. Russia
        11.2.4. Italy
        11.2.5. Spain
        11.2.6. U.K.
        11.2.7. Rest of Europe
   11.3. Market Size (US$ Mn) and Volume(Units) Forecast By Drug Type
        11.3.1. Stimulants
               11.3.1.1. Amphetamine (Adzenys XR ODT, Evekeo)
               11.3.1.2. Methylphenidate (Concerta, Daytrana)
               11.3.1.3. Dextroamphetamine (Dexedrine, ProCentra, Zenzedi)
               11.3.1.4. Dexmethylphenidate
               11.3.1.5. Lisdexamfetamine dimesylate (Vyvanse)
        11.3.2. Non stimulants
               11.3.2.1. Atomoxetine (Strattera)
               11.3.2.2. Bupropion
               11.3.2.3. Guanfacine (Intuniv)
               11.3.2.4. Clonidine (Kapvay)
   11.4. Market Size (US$ Mn) Forecast By Distribution Channel
        11.4.1. Specialty Clinics
        11.4.2. Hospital Pharmacies
        11.4.3. Retail Pharmacies
        11.4.4. E-commerce
   11.5. Market Size (US$ Mn) Forecast By Age Group
        11.5.1. Pediatric and neonates
        11.5.2. Adult
   11.6. Market Attractiveness Analysis
        11.6.1. By Country
        11.6.2. By Drug Type
        11.6.3. By Distribution Channel
        11.6.4. By Age Group 
   11.7. Prominent Trends
   11.8. Drivers and Restraints: Impact Analysis

12.  APAC Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Market Analysis and Forecast
   12.1. Introduction
        12.1.1. Basis Point Share (BPS) Analysis By Country / Region
        12.1.2. Y-o-Y Growth Projections By Country / Region
        12.1.3. Key Regulations
   12.2. Market Size (US$ Mn) and Forecast By Country / Region
        12.2.1. China
        12.2.2. India
        12.2.3. Japan
        12.2.4. Australia and New Zealand
        12.2.5. Rest of APAC
   12.3. Market Size (US$ Mn) and Volume(Units) Forecast By Drug Type
        12.3.1. Stimulants
               12.3.1.1. Amphetamine (Adzenys XR ODT, Evekeo)
               12.3.1.2. Methylphenidate (Concerta, Daytrana)
               12.3.1.3. Dextroamphetamine (Dexedrine, ProCentra, Zenzedi)
               12.3.1.4. Dexmethylphenidate
               12.3.1.5. Lisdexamfetamine dimesylate (Vyvanse)
        12.3.2. Non stimulants
               12.3.2.1. Atomoxetine (Strattera)
               12.3.2.2. Bupropion
               12.3.2.3. Guanfacine (Intuniv)
               12.3.2.4. Clonidine (Kapvay)
   12.4. Market Size (US$ Mn) Forecast By Distribution Channel
        12.4.1. Specialty Clinics
        12.4.2. Hospital Pharmacies
        12.4.3. Retail Pharmacies
        12.4.4. E-commerce
   12.5. Market Size (US$ Mn) Forecast By Age Group
        12.5.1. Pediatric and neonates
        12.5.2. Adult
   12.6. Market Attractiveness Analysis
        12.6.1. By Country
        12.6.2. By Drug Type
        12.6.3. By Distribution Channel
        12.6.4. By Age Group 
   12.7. Prominent Trends
   12.8. Drivers and Restraints: Impact Analysis

13.  MEA Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Market Analysis and Forecast
   13.1. Introduction
        13.1.1. Basis Point Share (BPS) Analysis By Country
        13.1.2. Y-o-Y Growth Projections By Country
        13.1.3. Key Regulations
   13.2. Market Size (US$ Mn) Forecast By Country
        13.2.1. GCC Countries
        13.2.2. South Africa
        13.2.3. Rest of MEA
   13.3. Market Size (US$ Mn) and Volume(Units) Forecast By Drug Type
        13.3.1. Stimulants
               13.3.1.1. Amphetamine (Adzenys XR ODT, Evekeo)
               13.3.1.2. Methylphenidate (Concerta, Daytrana)
               13.3.1.3. Dextroamphetamine (Dexedrine, ProCentra, Zenzedi)
               13.3.1.4. Dexmethylphenidate
               13.3.1.5. Lisdexamfetamine dimesylate (Vyvanse)
        13.3.2. Non stimulants
               13.3.2.1. Atomoxetine (Strattera)
               13.3.2.2. Bupropion
               13.3.2.3. Guanfacine (Intuniv)
               13.3.2.4. Clonidine (Kapvay)
   13.4. Market Size (US$ Mn) Forecast By Distribution Channel
        13.4.1. Specialty Clinics
        13.4.2. Hospital Pharmacies
        13.4.3. Retail Pharmacies
        13.4.4. E-commerce
   13.5. Market Size (US$ Mn) Forecast By Age Group
        13.5.1. Pediatric and neonates
        13.5.2. Adult
   13.6. Market Attractiveness Analysis
        13.6.1. By Country
        13.6.2. By Drug Type
        13.6.3. By Distribution Channel
        13.6.4. By Age Group 
   13.7. Prominent Trends
   13.8. Drivers and Restraints: Impact Analysis

14.  Competition Landscape
   14.1. Competition Dashboard
   14.2. Company Share Analysis (2015)
   14.3. Company Profiles (Details – Overview, Financials, Strategy, Recent Developments)
   14.4. Global Players
        14.4.1. Amedra Pharmaceuticals LLC
        14.4.2. Eli Lilly and Company
        14.4.3. Janssen Pharmaceuticals, Inc.
        14.4.4. Noven Pharmaceuticals, Inc.
        14.4.5. Novartis Pharmaceuticals Corporation 
        14.4.6. Shire
        14.4.7. GlaxoSmithKline
        14.4.8. Celltech Group Ltd.
        14.4.9. Purdue Pharma L.P.

15. Assumptions and Acronyms Used

16. Research Methodology


List of Tables

Table 01: North America ADHD Therapeutics Market Volume (Unit Mn) Analysis and Forecast By Drug Type, 2015–2024
Table 02: Latin America ADHD Therapeutics Market Volume (Unit Mn) Analysis and Forecast By Drug Type, 2015–2024
Table 03: Europe ADHD Therapeutics Market Volume (Unit Mn) Analysis and Forecast By Drug Type, 2015–2024
Table 04: APAC ADHD Therapeutics Market Volume (Unit Mn) Analysis and Forecast By Drug Type, 2015–2024
Table 05: MEA ADHD Therapeutics Market Volume (Unit Mn) Analysis and Forecast By Drug Type, 2015–2024
Table 06: Global ADHD Therapeutics Market Value (US$ Mn) Analysis and Forecast By Drug Type, 2015–2024
Table 07: Global ADHD Therapeutics Market Value (US$ Mn) Analysis and Forecast By Age Group, 2015–2024
Table 08: Global ADHD Therapeutics Market Value (US$ Mn) Analysis and Forecast By Distribution Channel, 2015–2024
Table 09: Global ADHD Therapeutics Market Value (US$ Mn) Analysis and Forecast By Region, 2015–2024
Table 10: North America ADHD Therapeutics Market Value (US$ Mn) Analysis and Forecast By Country, 2015–2024
Table 11: North America ADHD Therapeutics Market Value (US$ Mn) Analysis and Forecast By Drug Type, 2015–2024
Table 12: North America ADHD Therapeutics Market Value (US$ Mn) Analysis and Forecast By Age Group, 2015–2024
Table 13: North America ADHD Therapeutics Market Value (US$ Mn) Analysis and Forecast By Distribution Channel, 2015–2024
Table 14: Latin America ADHD Therapeutics Market Value (US$ Mn) Analysis and Forecast By Country, 2015–2024
Table 15: Latin America ADHD Therapeutics Market Value (US$ Mn) Analysis and Forecast By Drug Type, 2015–2024
Table 16: Latin America ADHD Therapeutics Market Value (US$ Mn) Analysis and Forecast By Age Group, 2015–2024
Table 17: Latin America ADHD Therapeutics Market Value (US$ Mn) Analysis and Forecast By Distribution Channel, 2015–2024
Table 18: Europe ADHD Therapeutics Market Value (US$ Mn) Analysis and Forecast By Country, 2015–2024
Table 19: Europe ADHD Therapeutics Market Value (US$ Mn) Analysis and Forecast By Drug Type, 2015–2024
Table 20: Europe ADHD Therapeutics Market Value (US$ Mn) Analysis and Forecast By Age Group, 2015–2024
Table 21: Europe ADHD Therapeutics Market Value (US$ Mn) Analysis and Forecast By Distribution Channel, 2015–2024
Table 22: APAC ADHD Therapeutics Market Value (US$ Mn) Analysis and Forecast By Country, 2015–2024
Table 23: APAC ADHD Therapeutics Market Value (US$ Mn) Analysis and Forecast By Drug Type, 2015–2024
Table 24: APAC ADHD Therapeutics Market Value (US$ Mn) Analysis and Forecast By Age Group, 2015–2024
Table 25: APAC ADHD Therapeutics Market Value (US$ Mn) Analysis and Forecast By Distribution Channel, 2015–2024
Table 26: MEA ADHD Therapeutics Market Value (US$ Mn) Analysis and Forecast By Country, 2015–2024
Table 27: MEA ADHD Therapeutics Market Value (US$ Mn) Analysis and Forecast By Drug Type, 2015–2024
Table 28: MEA ADHD Therapeutics Market Value (US$ Mn) Analysis and Forecast By Age Group, 2015–2024
Table 29: MEA ADHD Therapeutics Market Value (US$ Mn) Analysis and Forecast By Distribution Channel, 2015–2024


List of Figures

Figure 01: Global ADHD Therapeutics Market - Scenario Forecast, 2015-2024 (US$ Mn)
Figure 02 : Global ADHD Therapeutics Market, Stimulants Price Difference (US$) By Region, 2015
Figure 03 : Global ADHD Therapeutics Market, Stimulants Price Difference (US$) By Region, 2024
Figure 04 : Global ADHD Therapeutics Market, Non-stimulants Price Difference (US$) By Region, 2015
Figure 05 : Global ADHD Therapeutics Market, Non-stimulants Price Difference (US$) By Region, 2024
Figure 06 : Global ADHD Therapeutics Market Value (US$ Mn) & Y-o-Y Growth (%), 2015-2024
Figure 07 : Global ADHD Therapeutics Market Absolute $ Opportunity, 2016-2024
Figure 08 : Global ADHD Therapeutics Market Share Analysis (%) By Drug Type, 2016 & 2024
Figure 09 : Global ADHD Therapeutics Y-o-Y growth (%) By Drug Type, 2016-2024
Figure 10 : Global ADHD Therapeutics Market Value (US$ Mn) & Y-o-Y Growth (%) By Stimulants Drug type Segment, 2015-2024
Figure 11 : Global ADHD Therapeutics Market Absolute $ Opportunity By Stimulants Drug Type Segment, 2016-2024
Figure 12 : Global ADHD Therapeutics Market Value (US$ Mn) & Y-o-Y Growth (%) By Non-stimulants Drug type Segment, 2015-2024
Figure 13 : Global ADHD Therapeutics Market Absolute $ Opportunity By Non-stimulants Drug Type, 2016-2024
Figure 14: Global ADHD Therapeutics Market Attractiveness Analysis By Drug Type, 2016-2024
Figure 15 : Global ADHD Therapeutics Market Share Analysis (%) By Age Group, 2016 & 2024
Figure 16 : Global ADHD Therapeutics Y-o-Y growth (%) By Age Group, 2016-2024
Figure 17 : Global ADHD Therapeutics Market Value (US$ Mn) & Y-o-Y Growth (%) By Pediatric and Adolescent Age Group Segment, 2015-2024
Figure 18: Global ADHD Therapeutics Market Absolute $ Opportunity By Pediatric and Adolescent Age Group Segment, 2016-2024
Figure 19 : Global ADHD Therapeutics Market Value (US$ Mn) & Y-o-Y Growth (%) By Adults Age Group Segment, 2015-2024
Figure 20 : Global ADHD Therapeutics Market Absolute $ Opportunity By Adults Age Group Segment, 2016-2024
Figure 21: Global ADHD Therapeutics Market Attractiveness Analysis By Age Group, 2016-2024
Figure 22 : Global ADHD Therapeutics Market Share Analysis (%) By Distribution Channel, 2016 & 2024
Figure 23 : Global ADHD Therapeutics Y-o-Y growth (%) By Distribution Channel, 2016-2024
Figure 24 : Global ADHD Therapeutics Market Value (US$ Mn) & Y-o-Y Growth (%) By Specialty Clinics Distribution Channel Segment, 2015-2024
Figure 25: Global ADHD Therapeutics Market Absolute $ Opportunity By Specialty Clinics Distribution Channel Segment, 2016-2024
Figure 26 : Global ADHD Therapeutics Market Value (US$ Mn) & Y-o-Y Growth (%) By Hospital Pharmacies Distribution Channel Segment, 2015-2024
Figure 27: Global ADHD Therapeutics Market Absolute $ Opportunity By Hospital Pharmacies Distribution Channel Segment, 2016-2024
Figure 28 : Global ADHD Therapeutics Market Value (US$ Mn) & Y-o-Y Growth (%) By Retail Pharmacies Distribution Channel Segment, 2015-2024
Figure 29 : Global ADHD Therapeutics Market Absolute $ Opportunity By Retail Pharmacies Distribution Channel Segment, 2016-2024
Figure 30 : Global ADHD Therapeutics Market Value (US$ Mn) & Y-o-Y Growth (%) By e-Commerce Distribution Channel Segment, 2015-2024
Figure 31 : Global ADHD Therapeutics Market Absolute $ Opportunity By e-Commerce Distribution Channel Segment, 2016-2024
Figure 32: Global ADHD Therapeutics Market Attractiveness Analysis By Distribution Channel, 2016-2024
Figure 33: Global ADHD Therapeutics Market Share Analysis (%) By Region, 2016 & 2024
Figure 34: Global ADHD Therapeutics Y-o-Y growth (%) By Region, 2016-2024
Figure 35 : North America ADHD Therapeutics Market Value (US$ Mn) & Y-o-Y Growth (%), 2015-2024
Figure 36 : North America ADHD Therapeutics Market Absolute $ Opportunity, 2016-2024
Figure 37 : Latin America ADHD Therapeutics Market Value (US$ Mn) & Y-o-Y Growth (%), 2015-2024
Figure 38 : Latin America ADHD Therapeutics Market Absolute $ Opportunity, 2016-2024
Figure 39 : Europe ADHD Therapeutics Market Value (US$ Mn) & Y-o-Y Growth (%), 2015-2024
Figure 40 : Europe ADHD Therapeutics Market Absolute $ Opportunity, 2016-2024
Figure 41 : APAC ADHD Therapeutics Market Value (US$ Mn) & Y-o-Y Growth (%), 2015-2024
Figure 42 : APAC ADHD Therapeutics Market Absolute $ Opportunity, 2016-2024
Figure 43 : MEA ADHD Therapeutics Market Value (US$ Mn) & Y-o-Y Growth (%), 2015-2024
Figure 44 : MEA ADHD Therapeutics Market Absolute $ Opportunity, 2016-2024
Figure 45 : Global ADHD Therapeutics Market Attractiveness Analysis By Region, 2016-2024
Figure 46 : North America ADHD Therapeutics Market Share Analysis (%) By Country, 2016 & 2024
Figure 47 : North America ADHD Therapeutics Y-o-Y growth (%) By Country, 2016-2024
Figure 48 : U.S. ADHD Therapeutics Market Value (US$ Mn) & Y-o-Y Growth (%), 2015-2024
Figure 49 : U.S. ADHD Therapeutics Market Absolute $ Opportunity (US$ Mn), 2016-2024
Figure 50 : Canada ADHD Therapeutics Market Value (US$ Mn) & Y-o-Y Growth (%), 2015-2024
Figure 51 : Canada ADHD Therapeutics Market Absolute $ Opportunity (US$ Mn) 2016-2024
Figure 52 : North America ADHD Therapeutics Market Attractiveness Analysis By Country, 2016-2024
Figure 53 : North America ADHD Therapeutics Market Attractiveness Analysis By Drug type, 2016-2024
Figure 54 : North America ADHD Therapeutics Market Attractiveness Analysis By Age Group, 2016-2024
Figure 55 : North America ADHD Therapeutics Market Attractiveness Analysis By Distribution Channel, 2016-2024
Figure 56 : Latin America ADHD Therapeutics Market Share Analysis (%) By Country, 2016 & 2024
Figure 57 : Latin America ADHD Therapeutics Y-o-Y growth (%) By Country, 2016-2024
Figure 58 : Brazil ADHD Therapeutics Market Value (US$ Mn) & Y-o-Y Growth (%), 2015-2024
Figure 59 : Brazil ADHD Therapeutics Market Absolute $ Opportunity (US$ Mn), 2016-2024
Figure 60 : Mexico ADHD Therapeutics Market Value (US$ Mn) & Y-o-Y Growth (%), 2015-2024
Figure 61 : Mexico ADHD Therapeutics Market Absolute $ Opportunity (US$ Mn), 2016-2024
Figure 62 : Rest of Latin America ADHD Therapeutics Market Value (US$ Mn) & Y-o-Y Growth (%), 2015-2024
Figure 63 : Rest of Latin America ADHD Therapeutics Market Absolute $ Opportunity (US$ Mn), 2016-2024
Figure 64 : Latin America ADHD Therapeutics Market Attractiveness Analysis By Country, 2016–2024
Figure 65 : Latin America ADHD Therapeutics Market Attractiveness Analysis By Drug type, 2016-2024
Figure 66 : Latin America ADHD Therapeutics Market Attractiveness Analysis By Age Group, 2016-2024
Figure 67 : Latin America ADHD Therapeutics Market Attractiveness Analysis By Distribution Channel, 2016-2024
Figure 68 : Europe ADHD Therapeutics Market Share Analysis (%) By Country, 2016 & 2024
Figure 69 : Europe ADHD Therapeutics Y-o-Y growth (%) By Country, 2016–2024
Figure 70 : Germany ADHD Therapeutics Market Value (US$ Mn) & Y-o-Y Growth (%), 2015–2024
Figure 71 : Germany ADHD Therapeutics Market Absolute $ Opportunity (US$ Mn), 2016–2024
Figure 72 : France ADHD Therapeutics Market Value (US$ Mn) & Y-o-Y Growth (%), 2015–2024
Figure 73: France ADHD Therapeutics Market Absolute $ Opportunity (US$ Mn), 2016–2024
Figure 74 : Russia ADHD Therapeutics Market Value (US$ Mn) & Y-o-Y Growth (%), 2015–2024
Figure 75 : Russia ADHD Therapeutics Market Absolute $ Opportunity (US$ Mn), 2016–2024
Figure 76 : Italy ADHD Therapeutics Market Value (US$ Mn) & Y-o-Y Growth (%), 2015–2024
Figure 77 : Italy ADHD Therapeutics Market Absolute $ Opportunity (US$ Mn), 2016–2024
Figure 78 : Spain ADHD Therapeutics Market Value (US$ Mn) & Y-o-Y Growth (%), 2015–2024
Figure 79 : Spain ADHD Therapeutics Market Absolute $ Opportunity (US$ Mn), 2016–2024
Figure 80 : The U.K. ADHD Therapeutics Market Value (US$ Mn) & Y-o-Y Growth (%), 2015–2024
Figure 81 : The U.K. ADHD Therapeutics Market Absolute $ Opportunity (US$ Mn), 2016–2024
Figure 82 : Rest of Europe ADHD Therapeutics Market Value (US$ Mn) & Y-o-Y Growth (%), 2015–2024
Figure 83 : Rest of Europe ADHD Therapeutics Market Absolute $ Opportunity (US$ Mn), 2016–2024
Figure 84 : Europe ADHD Therapeutics Market Attractiveness Analysis By Country, 2016–2024
Figure 85 : Europe ADHD Therapeutics Market Attractiveness Analysis By Drug type, 2016–2024
Figure 86 : Europe ADHD Therapeutics Market Attractiveness Analysis By Age Group, 2016–2024
Figure 87 : Europe ADHD Therapeutics Market Attractiveness Analysis By Distribution Channel, 2016–2024
Figure 88 : APAC ADHD Therapeutics Market Share Analysis (%) By Country, 2016 & 2024
Figure 89 : APAC ADHD Therapeutics Y-o-Y growth (%) By Country, 2016–2024
Figure 90 : China ADHD Therapeutics Market Value (US$ Mn) & Y-o-Y Growth (%), 2015–2024
Figure 91 :China ADHD Therapeutics Market Absolute $ Opportunity (US$), 2016–2024
Figure 92 : India ADHD Therapeutics Market Value (US$ Mn) & Y-o-Y Growth (%), 2015–2024
Figure 93 : India ADHD Therapeutics Market Absolute $ Opportunity (US$ Mn), 2016–2024
Figure 94 : Japan ADHD Therapeutics Market Value (US$ Mn) & Y-o-Y Growth (%), 2015–2024
Figure 95 : Japan ADHD Therapeutics Market Absolute $ Opportunity (US$ Mn), 2016–2024
Figure 96 : Australia & New Zealand ADHD Therapeutics Market Value (US$ Mn) & Y-o-Y Growth (%), 2015–2024
Figure 97 : Australia & New Zealand ADHD Therapeutics Market Absolute $ Opportunity, 2016–2024
Figure 98 : Rest of APAC ADHD Therapeutics Market Value (US$ Mn) & Y-o-Y Growth (%), 2015–2024
Figure 99 : Rest of APAC ADHD Therapeutics Market Absolute $ Opportunity (US$ Mn), 2016–2024
Figure 100 : APAC ADHD Therapeutics Market Attractiveness Analysis By Country, 2016–2024
Figure 101 : APAC ADHD Therapeutics Market Attractiveness Analysis By Drug type, 2016–2024
Figure 102 : APAC ADHD Therapeutics Market Attractiveness Analysis By Age Group, 2016–2024
Figure 103 : APAC ADHD Therapeutics Market Attractiveness Analysis By Distribution Channel, 2016–2024
Figure 104 : MEA ADHD Therapeutics Market Share Analysis (%) By Country, 2016 & 2024
Figure 105 : MEA ADHD Therapeutics Y-o-Y growth (%) By Country, 2016–2024
Figure 106 : GCC Countries ADHD Therapeutics Market Value (US$ Mn) & Y-o-Y Growth (%), 2015–2024
Figure 107 : GCC Countries ADHD Therapeutics Market Absolute $ Opportunity (US$ Mn), 2016–2024
Figure 108 : South Africa ADHD Therapeutics Market Value (US$ Mn) & Y-o-Y Growth (%), 2015–2024
Figure 109 : South Africa ADHD Therapeutics Market Absolute $ Opportunity (US$ Mn) 2016–2024
Figure 110 : Rest of MEA ADHD Therapeutics Market Value (US$ Mn) & Y-o-Y Growth (%), 2015–2024
Figure 111 : Rest of MEA ADHD Therapeutics Market Absolute $ Opportunity (US$), 2016–2024
Figure 112:  MEA ADHD Therapeutics Market Attractiveness Analysis By Country, 2016–2024
Figure 113 : MEA ADHD Therapeutics Market Attractiveness Analysis By Drug type, 2016–2024
Figure 114 : MEA ADHD Therapeutics Market Attractiveness Analysis By Age Group, 2016–2024
Figure 115 : MEA ADHD Therapeutics Market Attractiveness Analysis By Distribution Channel, 2016–2024
Figure 116: Global ADHD Therapeutics Company Market Share Analysis, 2015